We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion...
Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward April 10, 2024 Philips confirms that further to communicating the main terms of the...
Philips convenes the Annual General Meeting of Shareholders 2024  March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the...
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office March 19, 2024   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX:...
Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity March 12, 2024 Cloud offering will help improve workflow...
Health technology leader Philips recognized as Clarivate Top 100 Global Innovator March 6, 2024 Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023...
Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024 February 29, 2024 New CT 5300 system provides more accurate and reliable imaging...
Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide February 28, 2024 At #ECR2024, company also debuting...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions